Melatonin: Deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase

Michael A Rogawski, R. H. Roth, G. K. Aghajanian

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Rat liver and brain slices were incubated in vitro with [3H]melatonin. Liver slices synthesized small amounts of [3H]5-methoxyindoleacetic acid [3H]5-MIAA) along with other melatonin metabolites including 6-hydroxymelatonin. Pretreatment of animals prior to killing with the irreversible monoamine oxidase inhibitor pargyline allowed [3H]5-methoxytryptamine ([3H]5-MT) to be recovered from the incubation. No [3H]5-MIAA or [3H]5-MT could be detected in incubations with hypothalamic slices or following intraventricular injection of [3H]melatonin. The possibility that the deacetylase aryl acylamidase was in part responsible for the deacetylation occurring in liver slices was examined. Liver aryl acylamidase was able to utilize [3H]melatonin as substrate to produce [3H]5-MT. Furthermore, the liver enzyme was inhibited by melatonin (K(i) 1 mM) when tested with the alternate substrate o-nitroacetanalide. Brain aryl acylamidase did not generate any detectable [3H]5-MT nor was it inhibited by melatonin. These results suggest that 5-MT is not formed in brain from melatonin although trace amounts of 5-MT in the periphery could be derived from this precursor.

Original languageEnglish (US)
Pages (from-to)1219-1226
Number of pages8
JournalJournal of Neurochemistry
Volume32
Issue number4
StatePublished - 1979
Externally publishedYes

Fingerprint

aryl acylamidase
5-Methoxytryptamine
Melatonin
Liver
Brain
Intraventricular Injections
Pargyline
Monoamine Oxidase Inhibitors
Substrates
Metabolites
Rats
Animals

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Melatonin : Deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase. / Rogawski, Michael A; Roth, R. H.; Aghajanian, G. K.

In: Journal of Neurochemistry, Vol. 32, No. 4, 1979, p. 1219-1226.

Research output: Contribution to journalArticle

@article{aef4f97a430d474491a9d7f1eb38a045,
title = "Melatonin: Deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase",
abstract = "Rat liver and brain slices were incubated in vitro with [3H]melatonin. Liver slices synthesized small amounts of [3H]5-methoxyindoleacetic acid [3H]5-MIAA) along with other melatonin metabolites including 6-hydroxymelatonin. Pretreatment of animals prior to killing with the irreversible monoamine oxidase inhibitor pargyline allowed [3H]5-methoxytryptamine ([3H]5-MT) to be recovered from the incubation. No [3H]5-MIAA or [3H]5-MT could be detected in incubations with hypothalamic slices or following intraventricular injection of [3H]melatonin. The possibility that the deacetylase aryl acylamidase was in part responsible for the deacetylation occurring in liver slices was examined. Liver aryl acylamidase was able to utilize [3H]melatonin as substrate to produce [3H]5-MT. Furthermore, the liver enzyme was inhibited by melatonin (K(i) 1 mM) when tested with the alternate substrate o-nitroacetanalide. Brain aryl acylamidase did not generate any detectable [3H]5-MT nor was it inhibited by melatonin. These results suggest that 5-MT is not formed in brain from melatonin although trace amounts of 5-MT in the periphery could be derived from this precursor.",
author = "Rogawski, {Michael A} and Roth, {R. H.} and Aghajanian, {G. K.}",
year = "1979",
language = "English (US)",
volume = "32",
pages = "1219--1226",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Melatonin

T2 - Deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase

AU - Rogawski, Michael A

AU - Roth, R. H.

AU - Aghajanian, G. K.

PY - 1979

Y1 - 1979

N2 - Rat liver and brain slices were incubated in vitro with [3H]melatonin. Liver slices synthesized small amounts of [3H]5-methoxyindoleacetic acid [3H]5-MIAA) along with other melatonin metabolites including 6-hydroxymelatonin. Pretreatment of animals prior to killing with the irreversible monoamine oxidase inhibitor pargyline allowed [3H]5-methoxytryptamine ([3H]5-MT) to be recovered from the incubation. No [3H]5-MIAA or [3H]5-MT could be detected in incubations with hypothalamic slices or following intraventricular injection of [3H]melatonin. The possibility that the deacetylase aryl acylamidase was in part responsible for the deacetylation occurring in liver slices was examined. Liver aryl acylamidase was able to utilize [3H]melatonin as substrate to produce [3H]5-MT. Furthermore, the liver enzyme was inhibited by melatonin (K(i) 1 mM) when tested with the alternate substrate o-nitroacetanalide. Brain aryl acylamidase did not generate any detectable [3H]5-MT nor was it inhibited by melatonin. These results suggest that 5-MT is not formed in brain from melatonin although trace amounts of 5-MT in the periphery could be derived from this precursor.

AB - Rat liver and brain slices were incubated in vitro with [3H]melatonin. Liver slices synthesized small amounts of [3H]5-methoxyindoleacetic acid [3H]5-MIAA) along with other melatonin metabolites including 6-hydroxymelatonin. Pretreatment of animals prior to killing with the irreversible monoamine oxidase inhibitor pargyline allowed [3H]5-methoxytryptamine ([3H]5-MT) to be recovered from the incubation. No [3H]5-MIAA or [3H]5-MT could be detected in incubations with hypothalamic slices or following intraventricular injection of [3H]melatonin. The possibility that the deacetylase aryl acylamidase was in part responsible for the deacetylation occurring in liver slices was examined. Liver aryl acylamidase was able to utilize [3H]melatonin as substrate to produce [3H]5-MT. Furthermore, the liver enzyme was inhibited by melatonin (K(i) 1 mM) when tested with the alternate substrate o-nitroacetanalide. Brain aryl acylamidase did not generate any detectable [3H]5-MT nor was it inhibited by melatonin. These results suggest that 5-MT is not formed in brain from melatonin although trace amounts of 5-MT in the periphery could be derived from this precursor.

UR - http://www.scopus.com/inward/record.url?scp=0018763776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018763776&partnerID=8YFLogxK

M3 - Article

C2 - 285213

AN - SCOPUS:0018763776

VL - 32

SP - 1219

EP - 1226

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -